Shinpoong Pharmaceutical Co Ltd Long-term Investment Intensity
Shinpoong Pharmaceutical Co Ltd long-term investment intensity. Shinpoong Pharmaceutical Co Ltd (019175) has a Long-term Investment Intensity of 2.8% as of September 2019. Long-term investments of ₩10.84 Billion represent 2.8% of total assets of ₩390.28 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Shinpoong Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Shinpoong Pharmaceutical Co Ltd (2014–2018)
Long-term investment intensity of Shinpoong Pharmaceutical Co Ltd from 2014 to 2018. This chart shows how Shinpoong Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 2.8%, reflecting long-term investments of ₩10.84 Billion against total assets of ₩390.28 Billion KRW.
Shinpoong Pharmaceutical Co Ltd Long-term Investment Intensity by Year (2014–2018)
Shinpoong Pharmaceutical Co Ltd long-term investment intensity by year from 2014 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Shinpoong Pharmaceutical Co Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Shinpoong Pharmaceutical Co Ltd.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 2.7% | ₩10.10 Billion | ₩380.95 Billion | ▼ -1.9 pp |
| 2017 | 4.5% | ₩17.49 Billion | ₩385.61 Billion | ▲ +0.2 pp |
| 2016 | 4.3% | ₩17.93 Billion | ₩416.49 Billion | ▼ -1.0 pp |
| 2015 | 5.3% | ₩21.70 Billion | ₩410.73 Billion | ▲ +1.0 pp |
| 2014 | 4.2% | ₩17.35 Billion | ₩409.30 Billion | — |